Public Health
National Health Policy 2017: Assurance for Whom?

Amit Sengupta

27th March 2017

 

The Government has finally approved the National Health Policy-2017, bringing to an end a two year long process. A draft of the policy was available since mid-2015 but it is believed that the government, at the Niti Ayog’s behest had been unhappy with some specific parts of the earlier draft that was critical of the private sector.

Experience with past National Health Policy documents (we have had two in the past – one in 1983 and one in 2002) have not been particularly positive. In the past the policy has seldom been actually followed ...

Read more...

Last Updated on Monday, 27 March 2017 06:55
 
Who Benefits from a Compromised World Health Organisation?

Amit Sengupta

13th February 2017

 

The World Health Organisation is set to elect a new Director General at the World Health Assembly in May 2017, marking the completion of two four-year terms of the current Director General, Margaret Chan. Three candidates were shortlisted at the recently concluded Executive Board meeting of the WHO in Geneva -- Sania Nishtar from Pakistan, David Nabarro from the UK and Tedros Adhanom Ghebreyesus from Ethiopia.

While, on the surface, it appears to ...

Read more...

Last Updated on Monday, 13 February 2017 07:10
 
A Year of Apathy Towards Public Health Services

Amit Sengupta

29th December 2016

 

The past year once again provides a clear picture of neglect of public health by the BJP led government and further, a disdain towards policies that promote welfare. The year has seen several outbreaks of infectious diseases such as dengue and chikungunya, often reaching epidemic proportions in many parts of the country. The epidemics have laid bare the inability of the country’s health systems to protect people’s health. Yet successive budgets presented by the BJP government have st ...

Read more...

Last Updated on Friday, 30 December 2016 08:27
 
Why Hand over a National Asset to Foreign MNCs?

Amit Sengupta

7th July 2016


FDI in Pharmaceuticals

In the recent slew of measures aimed at liberalisation of norms for Foreign Direct Investment (FDI), norms for the pharmaceuticals (medicine) sector have been further liberalized. Existing norms allowed for 100% FDI in the case of Greenfield projects (projects that involve infusion of FDI to set up a completely new facilit ...

Read more...

 
The Zika Crisis Needs a Global Response

Amit Sengupta

10th February 2016

 

Global concerns about a new viral pandemic have started making headlines barely weeks after resolution of the Ebola epidemic in West Africa. The virus responsible for panic buttons being pressed, with the WHO declaring a ‘public health emergency of international concern’, is the Zika virus. Threats to health at a global scale in the form of epidemics caused by viruses are now too frequent to view these threats as one-off events. ...

Read more...

 
«StartPrev12345678910NextEnd»

Page 1 of 14